FORM OF AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 26th, 2023 • Biodexa Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Amended and Restated Securities Purchase Agreement (this “Agreement”), dated as of May 25, 2023, and effective as of May 23, 2023, is between Biodexa Pharmaceuticals Plc, a public limited company organized under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
